NK Cells in Health and Disease
Open Access
- 27 May 2025
- journal article
- editorial
- Published by MDPI AG in Biomedicines
- Vol. 13 (6) , 1312
Abstract
Natural killer (NK) cells are cytotoxic innate lymphocytes that have a critical role in anti-viral and anti-tumour immunityKeywords
Funding Information
- Karyopharm Therapeutics
This publication has 9 references indexed in Scilit:
- The clinical landscape of CAR NK cellsExperimental Hematology & Oncology, 2025
- Natural Killer cells at the frontline in the fight against cancerCell Death & Disease, 2024
- Natural killer cell therapiesNature, 2024
- Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1/2 trialNature Medicine, 2024
- Harnessing natural killer cell effector function against cancerImmunotherapy Advances, 2023
- TIGIT, a novel immune checkpoint therapy for melanomaCell Death & Disease, 2023
- Impact of natural killer cells on outcomes after allogeneic hematopoietic stem cell transplantation: A systematic review and meta-analysisFrontiers in Immunology, 2022
- The HLA-B −21 dimorphism impacts on NK cell education and clinical outcome of immunotherapy in acute myeloid leukemiaBlood, 2019
- Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunityNature Immunology, 2018